Sarepta Therapeutics (SRPT) Intangibles (2010 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Intangibles of $31.4 million for Q1 2026, up 19.79% year-over-year from $26.2 million in Q1 2025, and up 8.41% quarter-over-quarter from $28.9 million in Q4 2025.
Sarepta Therapeutics (SRPT) Intangibles (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' Intangibles history runs 17 years deep, the most recent figure standing at $31.4 million for Q1 2026.
- In Q1 2026, Intangibles rose 19.79% year-over-year to $31.4 million; the TTM figure through Mar 2026 stood at $31.4 million (up 19.79% YoY), while the FY2025 annual figure was $28.9 million, up 7.67% from the prior year.
- Intangibles for Q1 2026 stood at $31.4 million, up from $28.9 million in the prior quarter.
- The five-year high for Intangibles was $31.4 million in Q1 2026, with the low at $7.2 million in Q1 2023.
- The 5-year median for Intangibles is $26.2 million (2025), against an average of $21.2 million.
- The sharpest annual moves came in 2022 and 2024: Intangibles sank 46.78% in 2022, then surged 301.86% in 2024.
- Sarepta Therapeutics' Intangibles stood at $7.6 million in 2022, then jumped by 31.96% to $10.0 million in 2023, then surged by 168.87% to $26.9 million in 2024, then advanced by 7.67% to $28.9 million in 2025, then gained by 8.41% to $31.4 million in 2026.
- Business Quant data shows SRPT's Intangibles at $31.4 million in Q1 2026, $28.9 million in Q4 2025, and $29.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | 30.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.61 Mn |
| Mar 31, 2026 | 31.38 Mn |
| Dec 31, 2025 | 28.95 Mn |
| Sep 30, 2025 | 29.68 Mn |
| Jun 30, 2025 | 30.52 Mn |
| Mar 31, 2025 | 26.20 Mn |
| Dec 31, 2024 | 26.89 Mn |
| Sep 30, 2024 | 27.57 Mn |
| Jun 30, 2024 | 28.25 Mn |
| Mar 31, 2024 | 28.93 Mn |
| Dec 31, 2023 | 10.00 Mn |
| Sep 30, 2023 | 19.50 Mn |
| Jun 30, 2023 | 18.02 Mn |
| Mar 31, 2023 | 7.20 Mn |
| Dec 31, 2022 | 7.58 Mn |
| Sep 30, 2022 | 13.06 Mn |
| Jun 30, 2022 | 13.06 Mn |
| Mar 31, 2022 | 13.33 Mn |
| Dec 31, 2021 | 14.24 Mn |
| Sep 30, 2021 | 14.20 Mn |